JF
ATYR

Jump Financial’s aTyr Pharma ATYR Stock Holding History

Jump Financial’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-49,904
Closed -$97.3K – 2353
2024
Q1 		$97.3K Buy
+49,904
New +$87K ﹤0.01% 1792
2022
Q1 		– Sell
-16,100
Closed -$120K – 1975
2021
Q4 		$120K Buy
+16,100
New +$134K 0.01% 1203

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return
CC
Checkpoint Capital San Francisco, California $279M AUM 45.74% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jump Financial's ATYR Position: Q2 2024 in Review

Jump Financial sold out of aTyr Pharma (ATYR) in Q2 2024, closing a stake of 49,904 shares — an estimated $97.3K sold.

Jump Financial first reported a position in ATYR in Q4 2021 and held it in 2 quarters. The position peaked at $120K in Q4 2021. 47 funds tracked by Wall St. Rank hold ATYR as of Q2 2024.

  • Jump Financial reported no remaining aTyr Pharma position as of Q2 2024 after selling out during the quarter.
  • Jump Financial sold 49,904 aTyr Pharma shares in Q2 2024, an estimated $97.3K.
  • Jump Financial first reported a position in aTyr Pharma in Q4 2021 and held it in 2 quarters.
  • Jump Financial's aTyr Pharma position peaked at $120K in Q4 2021.
  • 47 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2024.

Based on Jump Financial's 13F filing for Q2 2024, filed 14 Aug 2024.